Application Information

This drug has been submitted to the FDA under the reference 062645/001.

Names and composition

"ULTRAGRIS-165" is the commercial name of a drug composed of GRISEOFULVIN, ULTRAMICROCRYSTALLINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
062645/001 ULTRAGRIS-165 GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 165MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
061996/001 FULVICIN P/G GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 125MG
061996/002 FULVICIN P/G GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 250MG
061996/003 FULVICIN P/G 165 GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 165MG
061996/004 FULVICIN P/G 330 GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 330MG
062178/001 GRISACTIN ULTRA GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 125MG
062178/002 GRISACTIN ULTRA GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 250MG
062438/001 GRISACTIN ULTRA GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 165MG
062438/002 GRISACTIN ULTRA GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 330MG
062645/001 ULTRAGRIS-165 GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 165MG
062646/001 ULTRAGRIS-330 GRISEOFULVIN, ULTRAMICROCRYSTALLINE TABLET/ORAL 330MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved